Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 4/20 | 0.62 |
| ▸ | NPY1R | P25929 | 1/20 | 0.60 |
| ▸ | NPY2R | P49146 | 1/20 | 0.60 |
| ▸ | NPY4R | P50391 | 1/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.60 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.57 |
| ▸ | CALCA | P06881 | 2/20 | 0.56 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.56 |
| ▸ | CTSB | P07858 | 2/20 | 0.56 |
| ▸ | DPP3 | Q9NY33 | 2/20 | 0.55 |
| ▸ | TACR1 | P25103 | 1/20 | 0.55 |
| ▸ | EED | O75530 | 1/20 | 0.54 |
| ▸ | GLP1R | P43220 | 4/20 | 0.53 |
| ▸ | GIPR | P48546 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30320550 | 0.91 | NPY1R (0.64) | KISS1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29602399 | 0.90 | KISS1R (0.65) | KISS1RCXCR4CAPN1CTSBTACR1 | |
| SCHEMBL30605444 | 0.89 | NTSR2 (0.61) | KISS1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30432724 | 0.88 | NPY1R (0.58) | KISS1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30658391 | 0.87 | NPY2R (0.70) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL29445593 | 0.87 | KISS1R (0.61) | KISS1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30495771 | 0.87 | NPY1R (0.65) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30495674 | 0.87 | NPY1R (0.60) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30887981 | 0.86 | CALCA (0.65) | KISS1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30729468 | 0.86 | NPY1R (0.61) | KISS1RNPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250242039-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS | THORNHILL THERAPEUTICS INC (US) | 2025-07-31 | — | — | US | disclosed |
| US-20240299565-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS | APPLIED MOLECULAR TRANSPORT INC. | 2024-09-12 | — | — | US | disclosed |
| EP-4316586-A2 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | Applied Molecular Transport Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4082558-B1 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | APPLIED MOLECULAR TRANSPORT INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-20230158163-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS | THORNHILL THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| EP-4082558-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | Applied Molecular Transport Inc. (US) | 2022-11-02 | — | — | EP | disclosed |
| US-11426466-B2 | Toxin-derived delivery constructs for pulmonary delivery | APPLIED MOLECULAR TRANSPORT INC. (US) | 2022-08-30 | — | — | US | disclosed |
| EP-3762009-B1 | TOXIN-DERIVED DELIVERY CONSTRUCTS FOR ORAL DELIVERY | APPLIED MOLECULAR TRANSPORT INC (US) | 2022-05-11 | — | — | EP | disclosed |